Announcements
-
Winners of the 2020 UNC School of Medicine Well-Being Pilot Awards
The Center for Health Innovation and the UNC School of Medicine Office of Faculty Affairs and Leadership Development is pleased to announced the winners of the 2020 UNC School of Medicine Well-Being Pilot Awards. Thank you to all who submitted an application!
-
Winners of the 2020 Innovation Pilot Awards
The Center for Health Innovation is pleased to announced the winners of the 2020 Innovation Pilot Awards. Thank you to all who submitted an application!
News
-
UNC School of Medicine scientists are researching gene therapy for Angelman Syndrome
UNC School of Medicine researchers Drs. Mark Zylka and Ben Philpot are partnering with AskBio to develop a gene therapy treatment for Angelman syndrome, a rare neurogenetic disorder with no cure. Preclinical evidence has shown that gene therapy may improve motor outcomes and reduce seizures, potentially transforming the lives of people living with condition.
-
Recent Antiplatelet Therapy Study conducted at UNC is recognized as a top advancement in genomic medicine in 2019
The NIH National Human Genome Research Insititute’s Genomic Medicine Group named UNC Department of Medicine and UNC Eshelman School of Pharmacy’s study as one of the top 10 advances in genomic medicine in 2019. This study found that continuous use of clopidogrel in patients who are genetic “non-responders” is associated with adverse outcomes.
-
UNC OB-GYN and Radiology faculty are awarded NC TraCS grant to study non-invasive diagnosis of endometriosis methods
Drs. Erin Carey, Steven Young, Jorge Oldan, and Yueh Lee have received a $50,000 grant from NC TraCS to study non-surgical methods to diagnose endometriosis lesions. This grant will be used to study the usage of PET scans and MRI’s as tools for diagnosis.
-
UNC Researchers identify blood test which improves ability to monitor cancer patients after treatment
Dr. Gaorav Gupta and Dr. Bhisham Chera from UNC Lineberger Comprehensive Cancer Center led the study which found this blood test to be 99% accurate in detecting HPV-linked oropharyngeal cancer. This blood test provides a non-invasive option to monitor patients after finishing cancer treatment.